These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

260 related items for PubMed ID: 4825231

  • 1. A biochemical abnormality in cerebrotendinous xanthomatosis. Impairment of bile acid biosynthesis associated with incomplete degradation of the cholesterol side chain.
    Setoguchi T, Salen G, Tint GS, Mosbach EH.
    J Clin Invest; 1974 May; 53(5):1393-401. PubMed ID: 4825231
    [Abstract] [Full Text] [Related]

  • 2. Cholic acid biosynthesis: the enzymatic defect in cerebrotendinous xanthomatosis.
    Salen G, Shefer S, Cheng FW, Dayal B, Batta AK, Tint GS.
    J Clin Invest; 1979 Jan; 63(1):38-44. PubMed ID: 762246
    [Abstract] [Full Text] [Related]

  • 3. Identification of pentahydroxy bile alcohols in cerebrotendinous xanthomatosis: characterization of 5beta-cholestane-3alpha, 7alpha, 12alpha, 24xi, 25-pentol and 5beta-cholestane-3alpha, 7alpha, 12alpha, 23xi, 25-pentol.
    Shefer S, Dayal B, Tint GS, Salen G, Mosbach EH.
    J Lipid Res; 1975 Jul; 16(4):280-6. PubMed ID: 1141769
    [Abstract] [Full Text] [Related]

  • 4. Differences in hepatic levels of intermediates in bile acid biosynthesis between Cyp27(-/-) mice and CTX.
    Honda A, Salen G, Matsuzaki Y, Batta AK, Xu G, Leitersdorf E, Tint GS, Erickson SK, Tanaka N, Shefer S.
    J Lipid Res; 2001 Feb; 42(2):291-300. PubMed ID: 11181760
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A 25-hydroxylation pathway of cholic acid biosynthesis in man and rat.
    Shefer S, Cheng FW, Dayal B, Hauser S, Tint GS, Salen G, Mosbach EH.
    J Clin Invest; 1976 Apr; 57(4):897-903. PubMed ID: 181403
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Metabolism of potential precursors of chenodeoxycholic acid in cerebrotendinous xanthomatosis (CTX).
    Salen G, Shefer S, Mosbach EH, Hauser S, Cohen BI, Nicolau G.
    J Lipid Res; 1979 Jan; 20(1):22-30. PubMed ID: 438653
    [Abstract] [Full Text] [Related]

  • 11. Absolute configuration of pentahydroxy bile alcohols excreted by patients with cerebrotendinous xanthomatosis: a circular dichroism study.
    Dayal B, Salen G, Tint GS, Toome V, Shefer S, Mosbach EH.
    J Lipid Res; 1978 Feb; 19(2):187-90. PubMed ID: 632682
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Transformation of 4-cholesten-3-one and 7 alpha-hydroxy-4-cholesten-3-one into cholestanol and bile acids in cerebrotendinous xanthomatosis.
    Salen G, Shefer S, Tint GS.
    Gastroenterology; 1984 Aug; 87(2):276-83. PubMed ID: 6735073
    [Abstract] [Full Text] [Related]

  • 14. Chemical synthesis of 5beta-cholestane-3alpha, 7alpha, 24, 25-tetrol and its metabolism in the perfused rabbit liver.
    Kuramoto T, Cohen BI, Rothschild MA, Donor DA, Mosbach EH.
    J Biol Chem; 1978 Jul 10; 253(13):4688-92. PubMed ID: 659442
    [Abstract] [Full Text] [Related]

  • 15. Bile acid synthesis in cultured human hepatocytes: support for an alternative biosynthetic pathway to cholic acid.
    Axelson M, Ellis E, Mörk B, Garmark K, Abrahamsson A, Björkhem I, Ericzon BG, Einarsson C.
    Hepatology; 2000 Jun 10; 31(6):1305-12. PubMed ID: 10827156
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Identification of 5 beta-cholestane-3 alpha, 7 alpha, 12 alpha, 25, 26-pentol in cerebrotendinous xanthomatosis.
    Dayal B, Tint GS, Greeley DN, Williams TH, Salen G.
    Steroids; 1983 Oct 10; 42(4):441-8. PubMed ID: 6679948
    [Abstract] [Full Text] [Related]

  • 18. Isotopomer spectral analysis of intermediates of cholesterol synthesis in patients with cerebrotendinous xanthomatosis.
    Clarenbach JJ, Lindenthal B, Dotti MT, Federico A, Kelleher JK, von Bergmann K.
    Metabolism; 2005 Mar 10; 54(3):335-44. PubMed ID: 15736111
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Identification of (23S)-5beta-cholestane-3alpha, 7alpha, 12alpha, 23, 25-pentol in cerebrotendinous xanthomatosis.
    Hoshita T, Yasuhara M, Kihira K, Kuramoto T.
    Steroids; 1976 May 10; 27(5):657-64. PubMed ID: 941184
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.